The antiviral prophylaxis of post-transplant lymphoproliferative disorder

Springer Semin Immunopathol. 1998;20(3-4):437-53. doi: 10.1007/BF00838054.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Antibodies, Viral / blood
  • Antibody Specificity
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus / immunology
  • DNA, Viral / analysis
  • Epstein-Barr Virus Infections / complications
  • Epstein-Barr Virus Infections / immunology
  • Epstein-Barr Virus Infections / prevention & control*
  • Ganciclovir / therapeutic use
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / immunology
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunosuppression / adverse effects
  • Immunotherapy
  • Lymphoproliferative Disorders / prevention & control*
  • Lymphoproliferative Disorders / virology
  • Organ Transplantation / adverse effects*
  • Polymerase Chain Reaction
  • Risk Factors
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • DNA, Viral
  • Immunoglobulin G
  • Ganciclovir